Charles Rierson Iii - Ri-Med is categorized under Medical Equipment Rental in Birmingham, AL and active since 1999.
Charles Rierson Iii - Ri-Med was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Equipment Rental business, which does work in the B2B market, and is classified as a Medical Equipment Rental, under code number 532291 by the NAICS.
If you are seeking more information, feel free to contact Charles Rierson Iii at the company’s single location by writing to 516 Thorn Berry Lane, Birmingham, Alabama AL 35242 or by phoning (205) 991-0630. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Charles Rierson Iii - Ri-Med |
| Contact Person: | Charles Rierson Iii |
| Address: | 516 Thorn Berry Lane, Birmingham, Alabama 35242 |
| Phone Number: | (205) 991-0630 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Equipment Rental |
| SIC Code: | 7352 |
| NAICS Code: | 532291 |
| Share This Business: |
Charles Rierson Iii - Ri-Med was started in 1999 to provide professional Medical Equipment Rental under the SIC code 7352 and NAICS code 532291. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Rierson Iii for inquiries that concern Charles Rierson Iii - Ri-Med by calling the company number (205) 991-0630, as your correspondence is most welcome. Additionally, the physical location of the single location of Charles Rierson Iii - Ri-Med can be found at the coordinates as well as the street address 516 Thorn Berry Lane in Birmingham, Alabama 35242.
For its online presence, you may visit Charles Rierson Iii - Ri-Med’s website at and engage with its social media outlets through on Twitter and on Facebook.